Stem Cell-Paved Biobridge: A Merger of Exogenous and Endogenous Stem Cells Toward Regenerative Medicine in Stroke

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-319-66679-2_8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke

  2017cited by this paper
• Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke

  2017cited by this paper
• Chronic inflammation and apoptosis propagate in ischemic cerebellum and heart of non-human primates.

  2017cited by this paper
• Mesenchymal stem cells attenuate MRI‐identifiable injury, protect white matter, and improve long‐term functional outcomes after neonatal focal stroke in rats

  2017cited by this paper
• Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair

  2017cited by this paper
• Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered

  2017cited by this paper
• Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke

  2017cited by this paper
• Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients

  2017cited by this paper
• Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies

  2016cited by this paper
• Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study

  2016cited by this paper
• The Volume of the Spleen and Its Correlates after Acute Stroke.

  2016cited by this paper
• Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke

  2016cited by this paper
• Stroke and cardiac cell death: Two peas in a pod.

  2016cited by this paper
• Age exacerbates the CCR2/5-mediated neuroinflammatory response to traumatic brain injury

  2016cited by this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Brain Region‐Specific Histopathological Effects of Varying Trajectories of Controlled Cortical Impact Injury Model of Traumatic Brain Injury

  2016cited by this paper
• Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke.

  2016cited by this paper
• Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.

  2016cited by this paper
• Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine Stroke

  2016cited by this paper
• Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.

  2016cited by this paper
• Age of PISCES: stem-cell clinical trials in stroke.

  2016cited by this paper
• Microvesicles from brain-extract—treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke

  2016cited by this paper
• Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury

  2016cited by this paper
• Muse Cells: Nontumorigenic Pluripotent Stem Cells Present in Adult Tissues—A Paradigm Shift in Tissue Regeneration and Evolution

  2016cited by this paper
• Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases

  2016cited by this paper
• Bystander Effect Fuels Human Induced Pluripotent Stem Cell‐Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke

  2015cited by this paper
• Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later.

  2015cited by this paper
• Mitochondrial Crisis in Cerebrovascular Endothelial Cells Opens the Blood–Brain Barrier

  2015cited by this paper
• In vitro induction and differentiation of umbilical cord mesenchymal stem cells into neuron-like cells by all-trans retinoic acid.

  2015cited by this paper
• Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β

  2015cited by this paper
• CCR2 Antagonism Alters Brain Macrophage Polarization and Ameliorates Cognitive Dysfunction Induced by Traumatic Brain Injury

  2015cited by this paper
• Mouse Embryonic Stem Cell‐Derived Cells Reveal Niches that Support Neuronal Differentiation in the Adult Rat Brain

  2015cited by this paper
• Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities

  2015cited by this paper
• Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke

  2015cited by this paper
• Opportunities and Challenges: Stem Cell‐Based Therapy for the Treatment of Ischemic Stroke

  2015cited by this paper
• Stroke therapy: the potential of amniotic fluid-derived stem cells.

  2015cited by this paper
• Mechanisms and treatment of ischaemic stroke—insights from genetic associations

  2014cited by this paper
• Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia

  2014cited by this paper
• A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods

  2014cited by this paper
• Fetal stem cell transplantation: Past, present, and future.

  2014cited by this paper
• [Transplantation of human embryonic neural stem cells protects rats against cerebral ischemic injury].

  2014cited by this paper
• Modern medical management of acute ischemic stroke.

  2014cited by this paper
• Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials

  2014cited by this paper
• Intravenous Transplants of Human Adipose-Derived Stem Cell Protect the Brain from Traumatic Brain Injury-Induced Neurodegeneration and Motor and Cognitive Impairments: Cell Graft Biodistribution and Soluble Factors in Young and Aged Rats

  2014cited by this paper
• Intravenous Administration of Human Umbilical Cord Blood‐Derived AC133+ Endothelial Progenitor Cells in Rat Stroke Model Reduces Infarct Volume: Magnetic Resonance Imaging and Histological Findings

  2013cited by this paper
• Neuroprotective Effect of Human Placenta-Derived Cell Treatment of Stroke in Rats

  2013cited by this paper
• Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases.

  2013cited by this paper
• Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury

  2013cited by this paper
• Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke

  2013cited by this paper
• Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion

  2013cited by this paper
• Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis

  2013cited by this paper
• Splenectomy protects experimental rats from cerebral damage after stroke due to anti‐inflammatory effects

  2013cited by this paper
• An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside

  2013cited by this paper
• Mesenchymal stromal cells in transplantation rejection and tolerance.

  2013cited by this paper
• Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage

  2013cited by this paper
• Stem Cells for Neurovascular Repair in Stroke.

  2013cited by this paper
• Changes in Spleen Size in Patients with Acute Ischemic Stroke: A Pilot Observational Study

  2013cited by this paper
• Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system.

  2013cited by this paper
• Stem Cell Recruitment of Newly Formed Host Cells via a Successful Seduction? Filling the Gap between Neurogenic Niche and Injured Brain Site

  2013cited by this paper
• The stem cell secretome and its role in brain repair

  2013cited by this paper
• Macrophages in atherosclerosis: a dynamic balance

  2013cited by this paper
• Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection.

  2012cited by this paper
• Stem cell therapy in ischemic stroke

  2012cited by this paper
• Inflammatory Cytokines in Experimental and Human Stroke

  2012cited by this paper
• Intravenous Grafts Of Amniotic Fluid-Derived Stem Cells Induce Endogenous Cell Proliferation and Attenuate Behavioral Deficits in Ischemic Stroke Rats

  2012cited by this paper
• The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model.

  2012cited by this paper
• A Transient Decrease in Spleen Size Following Stroke Corresponds to Splenocyte Release into Systemic Circulation

  2012cited by this paper
• Transplantation of umbilical cord–derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives

  2012cited by this paper
• The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling

  2012cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• Human umbilical cord wharton's jelly mesenchymal stem cells do not transform to tumor‐associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells

  2012cited by this paper
• Pathophysiologic Cascades in Ischemic Stroke

  2012cited by this paper
• The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations

  2012cited by this paper
• Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II

  2011cited by this paper
• Mesenchymal Stem Cells Stimulate Endogenous Neurogenesis in the Subventricular Zone of Adult Mice

  2011cited by this paper
• Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

  2011cited by this paper
• The immunology of stroke: from mechanisms to translation

  2011cited by this paper
• Transplanted Stem Cell‐Secreted Vascular Endothelial Growth Factor Effects Poststroke Recovery, Inflammation, and Vascular Repair

  2011cited by this paper
• Sources of Adult Mesenchymal Stem Cells Applicable for Musculoskeletal Applications - A Systematic Review of the Literature

  2011cited by this paper
• Bone Marrow Stromal Cells Promote Skilled Motor Recovery and Enhance Contralesional Axonal Connections After Ischemic Stroke in Adult Mice

  2011cited by this paper
• Sterile inflammation: sensing and reacting to damage

  2010cited by this paper
• Human Mesenchymal Stromal Cells and their Derivative, SB623 Cells, Rescue Neural Cells via Trophic Support following in Vitro Ischemia

  2010cited by this paper
• Trophic factors and stem cells for promoting recovery in stroke.

  2010cited by this paper
• Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats.

  2010cited by this paper
• Attributes of adult stem cells

  2009cited by this paper
• “Small stem cells” in adult tissues: Very small embryonic‐like stem cells stand up!

  2009cited by this paper
• Notch-Induced Rat and Human Bone Marrow Stromal Cell Grafts Reduce Ischemic Cell Loss and Ameliorate Behavioral Deficits in Chronic Stroke Animals

  2009cited by this paper
• Human Umbilical Cord Blood Cell Grafts for Brain Ischemia

  2009cited by this paper
• Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

  2009cited by this paper
• Apoptotic mechanisms after cerebral ischemia.

  2009cited by this paper
• The spleen contributes to stroke‐induced neurodegeneration

  2008cited by this paper
• Genetic modification of stem cells for transplantation.

  2008cited by this paper
• Cell-based therapy in ischemic stroke

  2008cited by this paper
• Very small embryonic-like stem cells: characterization, developmental origin, and biological significance.

  2008cited by this paper
• Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke.

  2008cited by this paper
• In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems

  2008cited by this paper
• Sarcoma Derived from Cultured Mesenchymal Stem Cells

  2007cited by this paper
• Totipotent, pluripotent or unipotent stem cells: a complex regulatory enigma and fascinating biology.

  2007cited by this paper
• Bone Marrow‐Derived Mesenchymal Stem Cells Promote Neuronal Networks with Functional Synaptic Transmission After Transplantation into Mice with Neurodegeneration

  2007cited by this paper
• Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats.

  2006cited by this paper

• No citing papers are available for this paper.